Remove Pacemaker Remove Pediatrics Remove Tachycardia
article thumbnail

Early Experience with Ivabradine for Focal Atrial Tachycardia in Pediatric Patients with Congenital Heart Disease

HeartRhythm

Ivabradine is an anti-arrhythmic agent that reduces the heart rate through inhibition of the pacemaker current of the sinoatrial node. It has been used to treat both inappropriate sinus tachycardia and sinus tachycardia related to heart failure in children and adults.

article thumbnail

Arrhythmias in children undergoing orthotopic heart transplantation

Frontiers in Cardiovascular Medicine

Methods We performed a retrospective clinical data review of all consecutive pediatric patients (aged 2–18 years) who underwent orthotopic HT for advanced heart failure at our institution between January 2007 and January 2023. Three patients developed symptomatic sinus node dysfunction at 18, 25, and 38 days and received permanent pacemakers.

article thumbnail

Heart rate of 230 beats per minute

Dr. Smith's ECG Blog

so it must be a pediatric ECG. The ECG was done because the heart rate was 230 and the differential included SVT vs. sinus tachycardia. This is typical of pediatric ECGs because the fetal circulation depends on the right ventricle. What can you say about this ECG at a rate of 230 beats per minute?

article thumbnail

What kind of AV block is this? And why does she develop Ventricular Tachycardia?

Dr. Smith's ECG Blog

Shortly after isoprenalin infusion was initiated, there were short runs of ventricular tachycardia. Isoprenalin was discontinued, and a temporary transveous pacemaker was implanted. The patient stabilized following pacemaker placement. The following ECG was recorded during one of these episodes of VT.

article thumbnail

Cardioneuroablation for pediatric patients with functional sinus node dysfunction and paroxysmal atrioventricular block

Journal of Cardiovascular Electrophysiology

Objective Describe the methodology and role of CNA for treatment of pediatric patients with functional AVB or SP. with one documented SP after termination of atrial tachycardia at the 3-month follow-up. Methods This is a single-center, case series study. Post-CNA, the median longest pause was 1.3 s s (range 0.8–2.2)